Cypress Pharmaceutical, Inc. Receives FDA Approval of Levetiracetam Oral Solution

Jan 16, 2009 - Cypress Pharmaceutical, Inc., announced today that the U.S. FDA has granted final approval of the company's abbreviated new drug application for Levetiracetam Oral Solution, 100 mg/mL.

The details can be read here.